ABOUT

TEAM

Leadership Profiles

Tetra Bio-Pharma’s executive team, board of directors, and advisory committee are recognized experts in their respective fields including drug development, regulatory affairs, clinical research, intellectual property, marketing and medical affairs.

Together, the company’s leadership team provides an extensive background to support Tetra Bio-Pharma’s long-term vision to offer a diverse portfolio of cannabinoid-derived drugs to address unmet medical needs.

EXECUTIVE MANAGEMENT TEAM

Dr. Guy Chamberland, M.Sc., Ph.D., Master Herbalist, has served as Tetra Bio-Pharma’s Chief Executive Officer and Chief Scientific Officer since October 15, 2018. He held the positions of Interim Chief Executive Officer and Chief Scientific Officer respectively since April 2018 and June 2016. Dr. Chamberland’s extensive experience in both executive and scientific roles establish him as an expert in the biopharmaceutical space. Dr. Chamberland has more than two decades of experience in drug development for the North American pharmaceutical industry with specific expertise in regulatory affairs, and the development and management of clinical research protocols and clinical studies for botanical medicines. He was also a member of the investment committee of the venture capital fund, Fonds Bionvation, for 7 years.

Mr. Di Paola has over a decade of experience in audit, finance and accounting as an auditor for PricewaterhouseCoopers and BDO Canada and has been involved with numerous financing and spin-out transactions. He is currently Chief Financial Officer for Mondias Natural Products and UrbanGold Minerals Inc., both publicly traded companies on the TSX Venture.

Mr. Néron has more than 32 years of experience in the pharmaceutical industry with demonstrated success in numerous therapeutic sectors including cardiology, rheumatology, endocrinology, women’s health, asthma/COPD, OTC and dermatology where challenging the reimbursement landscape factored prominently in his role. Prior to joining Tetra Bio-Pharma he occupied a senior marketing position at Bausch Health Canada, formerly Valeant. Steeve has held various marketing, sales, finance, material management and business development positions and has worked to launch or rejuvenate numerous market leading pharmaceutical brands including Aerius™ (antihistamine), Altace™ (hypertension), Ezetrol™ (cholesterol), Eliquis™ (anti-coagulant), Lodalis™ (cholesterol) and Contrave™ (Obesity).

Mr. Béchard brings more than 25 years of experience in finance, venture capital, corporate banking and business development experience to his role as Executive Vice President, Corporate Development and Licensing. Prior to joining Tetra, Mr. Béchard was a Senior Member at RBC Lifesciences, delivering top quartile returns for two separate venture capital funds with investments in American Biotech companies. During his 12-year term as a venture capitalist, Mr. Béchard, was involved in numerous investments, served on the Boards of more than 30 life science companies and oversaw the negotiation of numerous strategic alliances, partnerships, and outright sales to both pharmaceutical and biotech companies including taking several companies public both in Canada and the U.S. Mr. Béchard has also held key operating roles for an R&D management company and a drug delivery company contributing to their growth as well as serving as a consultant to the biopharmaceutical industry providing start-up assistance in areas of fundraising, strategy, and business and corporate development.

BOARD OF DIRECTORS

Dr. Cheliak is the CEO of Panag Pharma, a Canadian biotech company focused on the development of novel cannabinoid-based formulations for the treatment of pain and inflammation. Dr. Cheliak has over 20 years of business experience in a wide variety of biotechnology fields, including vaccines, human genetics, oncology, neurology and anti-infective drug development and CRO services. In addition to having held executive positions in the public sector, he has extensive deal-making experience within the pharmaceutical industry, academic institutions and research hospitals including securing financing with both big and small pharma. He currently serves as a Director of Solarvest (SVS) and is Vice Chair of the Government of Canada’s Networks Centres of Excellence (NCE) Standing Selection Committee and Chair of the NCE Monitoring Committee providing advice and recommendations to the Government of Canada on funding of large national science and infrastructure initiatives. Dr. Cheliak has a Ph.D. in Genetics from the University of Alberta.

Until 2013, Greg Drohan served as President of the Board of Church and Dwight Canada Corp. While there, Drohan successfully merged the Church & Dwight and Carter-Horner businesses which led to the doubling of sales revenue and achieved #1 market share on brands such as Trojans, Oxi Clean, First Response, Rub A535 and Arm & Hammer. Following his successful 40-year career in the consumer products sector Mr. Drohan has established a management consulting practice. In addition to his board role at Church and Dwight, he also served as Director of the Ryerson University Alumni Relations Board. Drohan holds an MBA from York University and a BBM from Ryerson Polytechnical Institute.

Mr. Merton has over 20 years of financial and business experience, including 10 years as CFO for public companies involved in the capital markets. Following 12 years with Ernst & Young and KPMG, he transitioned from the audit stream into financial advisory work, as a Business Valuator, Forensic Accountant and Corporate Finance specialist. After leaving KPMG, Mr. Merton joined Atlas Tube Inc., as Vice-President, Special Projects. Since assisting in the sale of Atlas Tube, Mr. Merton became the CFO of Reko International Group Inc. In December 2014, Mr. Merton was elected by shareholders as a member of the inaugural Board of Directors of Aphria Inc. Approximately one year later, Mr. Merton resigned as a member of the Board and joined Aphria as its CFO. In this role, Mr. Merton is responsible for communication with all stakeholders and is a member of the executive management team responsible for the strategic direction of Aphria, as well as leading all acquisition discussions, budgeting, financing, financial reporting and internal controls. Mr. Merton is a Chartered Professional Accountant, a Chartered Accountant and is a Fellow of the Canadian Institute of Chartered Business Valuators (the “CICBV”).

SCIENTIFIC ADVISORY BOARD

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur at ex mauris. Vestibulum vulputate condimentum purus id dapibus. Fusce elementum tempor augue, eget tincidunt tortor posuere id. Vestibulum eu diam egestas, aliquam eros ac, pellentesque arcu. Donec vel nibh non lorem semper elementum. Proin cursus, mi et sodales ornare, arcu tellus pellentesque mauris, ut tempus magna ligula malesuada metus. Proin eget malesuada est. Curabitur sit amet leo ac quam cursus aliquet. Nunc vitae porttitor nisi. Cras vitae nulla id augue efficitur interdum. Quisque tempus ligula quis nibh lobortis, eu maximus orci dictum. Nulla a diam eget ex vestibulum rhoncus.

Suspendisse feugiat neque sit amet faucibus facilisis. Praesent nec sapien id odio ultrices lacinia vel ut lectus. Sed scelerisque luctus nisi eu luctus. Quisque a lorem eget ipsum venenatis ultricies quis ut velit. Suspendisse et auctor tellus. Fusce mauris lectus, semper in nisl sit amet, fringilla mollis odio. Praesent rhoncus, dui eget sodales fringilla, lectus ligula accumsan mauris, a malesuada lectus enim non tortor. Curabitur tincidunt, lacus ac condimentum vulputate, libero est vulputate enim, consequat tincidunt risus nunc quis arcu. Vivamus rutrum consectetur urna nec luctus. Vivamus nibh mauris, maximus at mi ac, rutrum faucibus tellus. Nam blandit urna et condimentum consectetur.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur at ex mauris. Vestibulum vulputate condimentum purus id dapibus. Fusce elementum tempor augue, eget tincidunt tortor posuere id. Vestibulum eu diam egestas, aliquam eros ac, pellentesque arcu. Donec vel nibh non lorem semper elementum. Proin cursus, mi et sodales ornare, arcu tellus pellentesque mauris, ut tempus magna ligula malesuada metus. Proin eget malesuada est. Curabitur sit amet leo ac quam cursus aliquet. Nunc vitae porttitor nisi. Cras vitae nulla id augue efficitur interdum. Quisque tempus ligula quis nibh lobortis, eu maximus orci dictum. Nulla a diam eget ex vestibulum rhoncus.

Suspendisse feugiat neque sit amet faucibus facilisis. Praesent nec sapien id odio ultrices lacinia vel ut lectus. Sed scelerisque luctus nisi eu luctus. Quisque a lorem eget ipsum venenatis ultricies quis ut velit. Suspendisse et auctor tellus. Fusce mauris lectus, semper in nisl sit amet, fringilla mollis odio. Praesent rhoncus, dui eget sodales fringilla, lectus ligula accumsan mauris, a malesuada lectus enim non tortor. Curabitur tincidunt, lacus ac condimentum vulputate, libero est vulputate enim, consequat tincidunt risus nunc quis arcu. Vivamus rutrum consectetur urna nec luctus. Vivamus nibh mauris, maximus at mi ac, rutrum faucibus tellus. Nam blandit urna et condimentum consectetur.

Dr. Arsenault is a family medicine practitioner and pain management expert and an associate professor of family medicine at Université de Sherbrooke. He has vast experience in clinical research and is a Clinical Physician Investigator (CPI) at DIEX Research.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur at ex mauris. Vestibulum vulputate condimentum purus id dapibus. Fusce elementum tempor augue, eget tincidunt tortor posuere id. Vestibulum eu diam egestas, aliquam eros ac, pellentesque arcu. Donec vel nibh non lorem semper elementum. Proin cursus, mi et sodales ornare, arcu tellus pellentesque mauris, ut tempus magna ligula malesuada metus. Proin eget malesuada est. Curabitur sit amet leo ac quam cursus aliquet. Nunc vitae porttitor nisi. Cras vitae nulla id augue efficitur interdum. Quisque tempus ligula quis nibh lobortis, eu maximus orci dictum. Nulla a diam eget ex vestibulum rhoncus.

Suspendisse feugiat neque sit amet faucibus facilisis. Praesent nec sapien id odio ultrices lacinia vel ut lectus. Sed scelerisque luctus nisi eu luctus. Quisque a lorem eget ipsum venenatis ultricies quis ut velit. Suspendisse et auctor tellus. Fusce mauris lectus, semper in nisl sit amet, fringilla mollis odio. Praesent rhoncus, dui eget sodales fringilla, lectus ligula accumsan mauris, a malesuada lectus enim non tortor. Curabitur tincidunt, lacus ac condimentum vulputate, libero est vulputate enim, consequat tincidunt risus nunc quis arcu. Vivamus rutrum consectetur urna nec luctus. Vivamus nibh mauris, maximus at mi ac, rutrum faucibus tellus. Nam blandit urna et condimentum consectetur.

Close Menu

STAY UPDATED.
GET THE LASTEST NEWS.